- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2020-003908-14.
Displaying page 1 of 1.
EudraCT Number: 2020-003908-14 | Sponsor Protocol Number: M-2020-371 | Start Date*: 2021-07-07 | ||||||||||||||||
Sponsor Name:Miltenyi Biomedicine GmbH | ||||||||||||||||||
Full Title: A pivotal Phase II randomised, multi-centre, open-label study to evaluate the efficacy and safety of MB-CART2019.1 compared to standard of care therapy in participants with relapsed/refractory diff... | ||||||||||||||||||
Medical condition: Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) LT (Ongoing) AT (Ongoing) NL (Ongoing) DE (Ongoing) IT (Ongoing) ES (Ongoing) HU (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
